{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:38:14Z","timestamp":1787740694521,"version":"build-2784847793"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Department of Biotechnology (DBT), Govt. of India"},{"name":"Science and Engineering Board Early Career Research Award","award":["ECR\/2016\/000007"],"award-info":[{"award-number":["ECR\/2016\/000007"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.biopha.2018.07.090","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:47:45Z","timestamp":1532393265000},"page":"1428-1440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Withaferin-A attenuates multiple low doses of Streptozotocin (MLD-STZ) induced type 1 diabetes"],"prefix":"10.1016","volume":"106","author":[{"given":"Sravani","family":"Tekula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0749-4555","authenticated-orcid":false,"given":"Amit","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha","family":"Anchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandraiah","family":"Godugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2018.07.090_bib0005","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1073\/pnas.74.6.2485","article-title":"Studies of streptozotocin-induced insulitis and diabetes","volume":"74","author":"Rossini","year":"1977","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2018.07.090_bib0010","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.biopha.2018.07.090_bib0015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4103\/0253-7613.194859","article-title":"Oropharyngeal aspiration of bleomycin: An alternative experimental model of pulmonary fibrosis developed in Swiss mice","volume":"48","author":"Bale","year":"2016","journal-title":"Indian J. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2018.07.090_bib0020","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1021\/mp400311j","article-title":"Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity","volume":"10","author":"Jain","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2018.07.090_bib0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.colsurfb.2017.01.038","article-title":"Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC)","volume":"153","author":"Godugu","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"3","key":"10.1016\/j.biopha.2018.07.090_bib0030","doi-asserted-by":"crossref","first-page":"e89919","DOI":"10.1371\/journal.pone.0089919","article-title":"Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid","volume":"9","author":"Godugu","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.biopha.2018.07.090_bib0035","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1002\/jps.24637","article-title":"Piperlongumine for enhancing oral bioavailability and cytotoxicity of docetaxel in triple\u2010negative breast cancer","volume":"104","author":"Patel","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.090_bib0040","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ptr.5792","article-title":"The role of plant\u2010derived products in pancreatitis: experimental and clinical evidence","volume":"31","author":"Anchi","year":"2017","journal-title":"Phytother. Res."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.090_bib0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4239\/wjd.v5.i2.176","article-title":"Phytotherapy in diabetes: review on potential mechanistic perspectives","volume":"5","author":"El-Abhar","year":"2014","journal-title":"World J. Diabetes"},{"issue":"4","key":"10.1016\/j.biopha.2018.07.090_bib0050","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2337\/diacare.26.4.1277","article-title":"Systematic review of herbs and dietary supplements for glycemic control in diabetes","volume":"26","author":"Yeh","year":"2003","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.biopha.2018.07.090_bib0055","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2174\/092986706776360860","article-title":"Antidiabetic agents from medicinal plants","volume":"13","author":"Jung","year":"2006","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.090_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S1984-82502015000100001","article-title":"Pancreatic beta cell protection\/regeneration with phytotherapy","volume":"51","author":"Hosseini","year":"2015","journal-title":"Braz. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2018.07.090_bib0065","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1021\/jo01017a015","article-title":"Constituents of Withania somnifera Dun. III. The side chain of Withaferin A","volume":"30","author":"Lavie","year":"1965","journal-title":"J. Org. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.090_bib0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ptr.2650010108","article-title":"Anti\u00e2\u20ac-stress activity of sitoindosides VII and VIII, new acylsterylglucosides from Withania somnifera","volume":"1","author":"Bhattacharya","year":"1987","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.090_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-8741(00)00309-3","article-title":"Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum","volume":"74","author":"Bhattacharya","year":"2001","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.090_bib0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jep.2004.04.004","article-title":"Anticarcinogenic activity of Withania somnifera Dunal against Daltons ascitic lymphoma","volume":"93","author":"Christina","year":"2004","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.090_bib0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-8741(99)00206-8","article-title":"Immunomodulatory activity of Withania somnifera","volume":"71","author":"Davis","year":"2000","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2018.07.090_bib0090","first-page":"1","article-title":"A small molecule inhibitor of NF\u03baB blocks ER stress and the NLRP3 inflammasome and prevents progression of pancreatitis","author":"Kanak","year":"2016","journal-title":"J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.090_bib0095","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00125-012-2813-9","article-title":"Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation","volume":"56","author":"SoRelle","year":"2013","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.biopha.2018.07.090_bib0100","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm.4145","article-title":"Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice","volume":"22","author":"Lee","year":"2016","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.090_bib0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/(SICI)1096-9896(199602)178:2<176::AID-PATH433>3.0.CO;2-8","article-title":"Beta\u2010cell apoptosis is responsible for the development of IDDM in the multiple low\u2010dose streptozotocin model","volume":"178","author":"O\u2019Brien","year":"1996","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.090_bib0110","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2337\/diabetes.48.4.706","article-title":"Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes","volume":"48","author":"Flodstrom","year":"1999","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.biopha.2018.07.090_bib0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2337\/db07-0993","article-title":"Inhibition of AMP-activated protein kinase protects pancreatic \u00ce\u00b2-cells from cytokine-mediated apoptosis and CD8+ T-Cells\u201cInduced cytotoxicity","volume":"57","author":"Riboulet-Chavey","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2018.07.090_bib0120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/026119290403201s67","article-title":"Animal experimentation and ethics in India: the CPCSEA makes a difference","volume":"32","author":"Pereira","year":"2004","journal-title":"Altern. Lab. Anim.: ATLA"},{"issue":"1","key":"10.1016\/j.biopha.2018.07.090_bib0125","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1186\/s40064-016-3267-1","article-title":"Natural flavonoids silymarin and quercetin improve the brain distribution of co-administered P-gp substrate drugs","volume":"5","author":"Reddy","year":"2016","journal-title":"SpringerPlus"},{"issue":"18","key":"10.1016\/j.biopha.2018.07.090_bib0130","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1158\/0008-5472.CAN-08-1510","article-title":"Withaferin A causes FOXO3a-and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo","volume":"68","author":"Stan","year":"2008","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.biopha.2018.07.090_bib0135","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm.4145","article-title":"Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice","volume":"22","author":"Lee","year":"2016","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.090_bib0140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bcp.2015.07.024","article-title":"Withaferin-A reduces acetaminophen-induced liver injury in mice","volume":"97","author":"Jadeja","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2018.07.090_bib0145","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/bjp.2008.311","article-title":"Novel role of curcumin in the prevention of cytokine\u00e2\u20ac\u2013induced islet death in vitro and diabetogenesis in vivo","volume":"155","author":"Kanitkar","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.090_bib0150","first-page":"33","article-title":"A potential therapeutic strategy for diabetes and its complications in the form of co-encapsulated antioxidant nanoparticles (NanoCAPs) of ellagic acid and coenzyme Q10: preparation and evaluation in streptozotocin induced diabetic rats","volume":"4","author":"Ratnam","year":"2008","journal-title":"J. Biomed. Nanotechnol."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.090_bib0155","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.090_bib0160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","article-title":"Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver","volume":"582","author":"Moron","year":"1979","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"10.1016\/j.biopha.2018.07.090_bib0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jtemb.2018.01.016","article-title":"Nanoceria ameliorates doxorubicin induced cardiotoxicity: possible mitigation via reduction of oxidative stress and inflammation","volume":"47","author":"Sangomla","year":"2018","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2018.07.090_bib0170","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2217\/nnm.12.31","article-title":"Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin","volume":"7","author":"Jain","year":"2012","journal-title":"Nanomedicine"},{"issue":"1-2","key":"10.1016\/j.biopha.2018.07.090_bib0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2018.07.090_bib0180","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pupt.2018.06.003","article-title":"Oropharyngeal administration of silica in Swiss mice: a robust and reproducible model of occupational pulmonary fibrosis","volume":"51","author":"Karkale","year":"2018","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.090_bib0185","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0168-8227(99)00030-3","article-title":"Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes","volume":"44","author":"Takamura","year":"1999","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.biopha.2018.07.090_bib0190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cbi.2014.09.017","article-title":"Selenium nanoparticles involve HSP-70 and SIRT1 in preventing the progression of type 1 diabetic nephropathy","volume":"223","author":"Kumar","year":"2014","journal-title":"Chem. Biol. Interact."},{"issue":"9","key":"10.1016\/j.biopha.2018.07.090_bib0195","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1128\/MCB.25.9.3620-3629.2005","article-title":"Caspase-3-dependent \u03b2-cell apoptosis in the initiation of autoimmune diabetes mellitus","volume":"25","author":"Liadis","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"10","key":"10.1016\/j.biopha.2018.07.090_bib0200","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.2337\/diacare.27.10.2568","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Rathmann","year":"2004","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.biopha.2018.07.090_bib0205","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/diab.40.4.405","article-title":"Role of oxidative stress in development of complications in diabetes","volume":"40","author":"Baynes","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2018.07.090_bib0210","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cbi.2015.11.032","article-title":"Challenges and issues with streptozotocin-induced diabetes\u2013a clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics","volume":"244","author":"Goyal","year":"2016","journal-title":"Chem. Biol. Interact."},{"issue":"47","key":"10.1016\/j.biopha.2018.07.090_bib0215","first-page":"1","article-title":"Streptozotocin\u2010induced diabetic models in mice and rats","volume":"5","author":"Furman","year":"2015","journal-title":"Curr. Protoc. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.090_bib0220","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2009.21","article-title":"The role of inflammation in insulitis and \u03b2-cell loss in type 1 diabetes","volume":"5","author":"Eizirik","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2018.07.090_bib0225","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/bjp.2008.311","article-title":"Novel role of curcumin in the prevention of cytokine\u2010induced islet death in vitro and diabetogenesis in vivo","volume":"155","author":"Kanitkar","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"5684","key":"10.1016\/j.biopha.2018.07.090_bib0230","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/276182a0","article-title":"Complete protection from low-dose streptozotocin-induced diabetes in mice","volume":"276","author":"Rossini","year":"1978","journal-title":"Nature"},{"issue":"04","key":"10.1016\/j.biopha.2018.07.090_bib0235","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1055\/s-0029-1211291","article-title":"Immune intervention in type I diabetes mellitus\u2014current clinical and experimental approaches","volume":"102","author":"Kolb","year":"1994","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"4","key":"10.1016\/j.biopha.2018.07.090_bib0240","first-page":"334","article-title":"Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review","volume":"5","author":"Mishra","year":"2000","journal-title":"Altern. Med. Rev."},{"issue":"7","key":"10.1016\/j.biopha.2018.07.090_bib0245","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1074\/jbc.M606728200","article-title":"Withaferin A strongly elicits I\u00ce\u00baB kinase \u00ce\u00b2 hyperphosphorylation concomitant with potent inhibition of its kinase activity","volume":"282","author":"Kaileh","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2018.07.090_bib0250","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10565-016-9340-2","article-title":"Assessment of hepatoprotective and nephroprotective potential of withaferin A on bromobenzene-induced injury in Swiss albino mice: possible involvement of mitochondrial dysfunction and inflammation","volume":"32","author":"Vedi","year":"2016","journal-title":"Cell Biol. Toxicol."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.090_bib0255","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bcp.2014.08.004","article-title":"Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKK\u03b2","volume":"91","author":"Heyninck","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2018.07.090_bib0260","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4103\/0253-7613.16859","article-title":"Partial protective effect of rutin on multiple low dose streptozotocin-induced diabetes in mice","volume":"37","author":"Srinivasan","year":"2005","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.07.090_bib0265","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.biopha.2017.04.002","article-title":"Is Withaferin A, a magic bullet for metabolic syndrome?","volume":"92","author":"Santhekadur","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.07.090_bib0270","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2016.10.003","article-title":"Withaferin A induces Nrf2-dependent protection against liver injury: role of Keap1-independent mechanisms","volume":"101","author":"Palliyaguru","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.090_bib0275","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1172\/JCI8185","article-title":"IL-1\u03b1, IL-1\u03b2, and IFN-\u03b3 mark \u03b2 cells for Fas-dependent destruction by diabetogenic CD4+ T lymphocytes","volume":"105","author":"Amrani","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.biopha.2018.07.090_bib0280","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0006-2952(97)00492-9","article-title":"Cytokines and their roles in pancreatic islet \u03b2-cell destruction and insulin-dependent diabetes mellitus","volume":"55","author":"Rabinovitch","year":"1998","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.090_bib0285","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.0.CO;2-V","article-title":"An update on cytokines in the pathogenesis of insulin\u2010dependent diabetes mellitus","volume":"14","author":"Rabinovitch","year":"1998","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.090_bib0290","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1006\/jaut.2001.0506","article-title":"A transcriptional inhibitor of TNF-\u03b1 prevents diabetes induced by multiple low-dose streptozotocin injections in mice","volume":"16","author":"Holstad","year":"2001","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.biopha.2018.07.090_bib0295","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diab.46.6.937","article-title":"Treatment with neutralizing antibodies specific for IL-1\u03b2 prevents cyclophosphamide-induced diabetes in nonobese diabetic mice","volume":"46","author":"Cailleau","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2018.07.090_bib0300","series-title":"Alginate-Based Three-Dimensional In Vitro Tumor Models: A Better Alternative to Current Two-Dimensional Cell Culture Models, Alginates and Their Biomedical Applications","first-page":"157","author":"Khurana","year":"2018"},{"key":"10.1016\/j.biopha.2018.07.090_bib0305","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jchromb.2018.06.002","article-title":"First report on the pharmacokinetic profile of nimbolide, a novel anticancer agent in oral and intravenous administrated rats by LC\/MS method","volume":"1092","author":"Baira","year":"2018","journal-title":"J. Chromatogr. B"},{"issue":"4","key":"10.1016\/j.biopha.2018.07.090_bib0310","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2016015798","article-title":"Overview on therapeutic applications of microparticulate drug delivery systems","volume":"33","author":"Bale","year":"2016","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"10.1016\/j.biopha.2018.07.090_bib0315","series-title":"Nanotoxicology: Toxicity and Risk Assessment of Nanomaterials, Nanomaterials in Chromatography","first-page":"437","author":"Saifi","year":"2018"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218325939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218325939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:50:13Z","timestamp":1762311013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218325939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":63,"alternative-id":["S0753332218325939"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.090","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Withaferin-A attenuates multiple low doses of Streptozotocin (MLD-STZ) induced type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}